V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 320003860 | 320002354 | 1.65 | 63.4 | Palliative (P) | 2017-07-18 | 2017-07-22 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 320007257 | CETUXIMAB |
| 320003861 | 320002355 | 1.72 | 97 | Palliative (P) | null | 2018-10-21 | CNS LGG | N | N | 320007262 | CARBOPLATIN + VINORELBINE |
| 320003862 | 320002356 | 1.78 | 85.6 | null | 2016-03-17 | 2016-03-19 | PEMBROLIZUMAB | 02 | null | 320007402 | OXALIPLATIN + MDG |
| 320003863 | 320002357 | null | null | Palliative (P) | 2015-08-27 | 2015-08-27 | Fluorouricil + Folonic Acid (MdG) | N | N | 320007548 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320003864 | 320002358 | 1.65 | 80.6 | Curative (C) | 2018-05-16 | 2018-05-20 | Cisplatin + Fluorouracil + RT 5day | 02 | Y | 320007568 | CARBOPLATIN + VINORELBINE |
| 320003865 | 320002358 | 1.53 | 66.8 | Curative (C) | 2014-09-27 | 2017-09-21 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | N | 320007568 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320003866 | 320002359 | 1.8 | 67.8 | Disease modification (D) | 2017-11-26 | 2017-12-08 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 320007638 | CISPLATIN + GEMCITABINE |
| 320003867 | 320002360 | 1.55 | 100 | Palliative (P) | 2018-01-19 | 2018-01-19 | Cisplatin + Docetaxel +Fluorouracil | N | N | 320007680 | EOX |
| 320003868 | 320002361 | 1.7 | 66 | Curative (C) | 2017-08-16 | 2017-08-16 | Cisplatin + Docetaxel +Fluorouracil | 02 | Y | 320007716 | CARBOPLATIN + RT |
| 320003869 | 320002362 | 1.6 | 60 | Palliative (P) | 2018-05-22 | 2018-06-02 | Liposomal Doxorubicin 40mg/m2 | N | N | 320007731 | PACLITAXEL |
| 320003870 | 320002363 | 1.71 | 106 | Palliative (P) | 2015-01-03 | 2015-01-19 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | N | 320007744 | CISPLATIN + GEMCITABINE |
| 320003871 | 320005094 | 1.67 | 59.4 | Palliative (P) | 2015-05-28 | 2015-06-11 | Bevacizumab+Carbo+Pacliaxel | 02 | N | 320007751 | CISPLATIN + GEMCITABINE |
| 320003872 | 320002364 | 1.7 | 90 | Neo-adjuvant (N) | 2013-10-18 | 2013-10-25 | Cisplatin + Etoposide (3 day) | 2 | N | 320007775 | CAPECITABINE + MITOMYCIN |
| 320003873 | 320002365 | 1.55 | 58.7 | Curative (C) | 2015-08-21 | 2015-09-11 | Docetaxel+Gemcitabine (no prior RT) | N | Y | 320007789 | CETUXIMAB + RT |
| 320003874 | 320002366 | 1.79 | 86 | Palliative (P) | 2016-06-16 | 2016-06-22 | CETUXIMAB + RT | N | N | 320007806 | TRIAL |
| 320003875 | 320002367 | 1.81 | 59 | Curative (C) | 2017-04-05 | 2017-04-25 | Trial Unspecified | N | N | 320007862 | PEMBROLIZUMAB |
| 320003876 | 320002368 | 1.8 | 107.7 | Curative (C) | 2014-05-24 | 2014-05-27 | CISPLATIN + ETOPOSIDE | N | Y | 320007895 | TEMOZOLOMIDE + RT |
| 320003877 | 320002369 | 1.68 | null | Palliative (P) | null | 2017-12-11 | Capecitabine (21days) + Carboplatin | N | N | 320007896 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320003878 | 320002370 | 1.65 | 53.3 | Adjuvant (A) | 2014-09-20 | 2014-09-21 | Bevacizumab + CARBOPLATIN + GEMCITABINE | N | N | 320007898 | OXALIPLATIN + MDG |
| 320003879 | 320002371 | 0 | 67.4 | Palliative (P) | null | 2014-07-08 | Trial Unspecified | N | N | 320007902 | ICON TRIAL |
| 320003880 | 320002372 | 1.67 | 69 | Palliative (P) | 2016-10-25 | 2016-10-25 | Cisplatin + Fluorouracil + RT 5day | 02 | null | 320007909 | CARBOPLATIN + RT |
| 320003881 | 320002373 | 1.63 | 62.8 | Adjuvant (A) | 2017-12-24 | 2017-12-26 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 320007943 | CARBOPLATIN + RT |
| 320003882 | 320002374 | 1.6 | 80.2 | Neo-adjuvant (N) | 2016-10-15 | 2016-10-18 | CHOP R - 21 days | N | N | 320007961 | BEP |
| 320003883 | 320002375 | 1.85 | 59.8 | Disease modification (D) | 2017-05-31 | 2017-06-16 | CNS Choriod Plexus SIOP 2009, CycEV | 02 | null | 320007976 | ECX |
| 320003884 | 320002376 | 1.63 | 97 | Neo-adjuvant (N) | 2013-04-14 | 2013-04-27 | CNS LGG | N | N | 320007990 | CISPLATIN + FLUOROURACIL + RT |
| 320003885 | 320002377 | 1.7 | 71.2 | Palliative (P) | null | 2015-03-14 | Gemcitabine 1000mg/m2 D1 8 15 | null | null | 320008040 | CISPLATIN + GEMCITABINE |
| 320003886 | 320005095 | 1.69 | 106 | Neo-adjuvant (N) | 2015-02-12 | 2015-02-12 | Carbo F | Y | N | 320008079 | GEMCITABINE |
| 320003887 | 320005095 | 1.75 | 106.2 | Palliative (P) | 2015-01-04 | 2015-01-10 | GEMCITABINE | N | N | 320008079 | CVP R |
| 320003888 | 320002378 | null | 58.2 | Neo-adjuvant (N) | 2019-03-01 | 2019-03-16 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 320008117 | VINCRISTINE |
| 320003889 | 320002379 | 1.63 | 52.4 | Curative (C) | 2016-03-21 | 2016-03-24 | CISPLATIN + VINORELBINE | 02 | Y | 320008142 | CAPECITABINE + OXALIPLATIN |
| 320003890 | 320002380 | 1.79 | 108.4 | Neo-adjuvant (N) | 2015-09-15 | 2015-09-16 | BCG Intravesical | N | N | 320008163 | CISPLATIN + GEMCITABINE |
| 320003891 | 320002381 | 1.75 | 78 | Palliative (P) | 2017-11-10 | 2017-11-13 | Mitomycin Intravesical | 02 | null | 320008178 | NOT MATCHED |
| 320003892 | 320002382 | 1.68 | 74.6 | null | 2016-06-06 | 2016-06-07 | Cisplatin + Pemetrexed | 02 | N | 320008192 | CETUXIMAB |
| 320003893 | 320005096 | 1.85 | 80 | Adjuvant (A) | 2015-05-10 | 2015-05-17 | Trial Unspecified | N | N | 320008212 | EVEROLIMUS |
| 320003894 | 320005096 | 1.76 | 62.3 | Curative (C) | 2013-11-28 | 2013-12-19 | Cisplatin + Docetaxel +Fluorouracil | null | Y | 320008212 | CARBOPLATIN + PEMETREXED |
| 320003895 | 320002383 | null | 75.9 | Adjuvant (A) | 2016-09-13 | 2016-09-28 | CAPECITABINE + OXALIPLATIN | N | N | 320008270 | CETUXIMAB + RT |
| 320003896 | 320002384 | 1.6 | 54.8 | Palliative (P) | 2016-03-02 | 2016-03-11 | EOX | N | N | 320008313 | CARBOPLATIN + LIPOSOMAL DOX |
| 320003897 | 320002384 | 1.6 | 59.4 | Palliative (P) | 2014-05-08 | 2014-05-27 | Bevacizumab 7.5mg/kg | N | N | 320008313 | BEVACIZUMAB |
| 320003898 | 320002384 | 1.67 | 56 | Adjuvant (A) | 2016-04-08 | 2016-04-26 | Cisplatin + Etoposide (3 day) | 2 | N | 320008313 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320003899 | 320002385 | 1.55 | 0 | Palliative (P) | 2015-06-19 | 2015-06-30 | Cisplatin + Pemetrexed | N | N | 320008340 | IVADO |
| 320003900 | 320002386 | null | 69 | Palliative (P) | 2016-02-15 | 2016-02-26 | Carboplatin + Etoposide iv&po | N | N | 320008350 | BCG |
| 320003901 | 320002387 | null | null | null | 2017-08-25 | 2017-08-25 | Oxaliplatin + Modified de Gramont | N | null | 320008489 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320003902 | 320002388 | 1.58 | 54 | Palliative (P) | 2015-07-10 | 2016-07-28 | GEMCITABINE + RT | N | N | 320008509 | BLEOMYCIN |
| 320003903 | 320002389 | 1.73 | 0 | Neo-adjuvant (N) | 2014-08-09 | 2014-08-21 | Carboplatin + Etoposide iv&po | 2 | N | 320008516 | DOCETAXEL |
| 320003904 | 320002390 | 1.6 | 80 | Adjuvant (A) | 2015-08-23 | 2015-09-20 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 320008522 | CARBOPLATIN + RT |
| 320003905 | 320002391 | 1.66 | null | Not known (9) | 2017-06-11 | 2017-06-22 | Cisplatin + Docetaxel +Fluorouracil | N | N | 320008528 | CETUXIMAB + RT |
| 320003906 | 320002392 | 1.87 | 68.1 | null | 2019-03-17 | 2019-03-25 | CARBOPLATIN + RT | 02 | N | 320008576 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320003907 | 320002393 | 1.8 | 61.8 | Palliative (P) | 2016-01-10 | 2016-01-13 | Bevacizumab 7.5mg/kg | N | N | 320008580 | TIP |
| 320003908 | 320002394 | 1.7 | null | 1 | 2017-10-06 | 2017-10-08 | EOX | N | null | 320008581 | NOT MATCHED |
| 320003909 | 320005098 | 1.66 | 76.1 | Palliative (P) | 2016-04-29 | 2016-05-05 | CARBOPLATIN + RT | 02 | N | 320008585 | CISPLATIN + GEMCITABINE |